TP53 and breast carcinoma: Analysis of total and phosphoprotein data from the TCGA provisional breast cancer cohort, similarly identified disruption to PI3K/AKT/mTOR signalling, p38/MAPK (Toll-like signalling) and p53 DNA damage checkpoint responses (Figure S4A and S4B).